New Medical Solutions curates credible advances that solve real problems in healthcare—faster diagnosis, safer procedures, better monitoring, smoother coordination, and fairer access.
AstraZeneca is pouring $136 million more into the expansion of an inhalants production base in China, bringing its total investment at the site to $886 million.
Teva issued a voluntary recall of 580,844 bottles of the widely used blood pressure medication prazosin hydrochloride, citing unacceptable levels of potentially cancer-causing impurities.
Patients hoping to get their hands on a cheaper copycat of Johnson & Johnson’s fading anti-inflammatory blockbuster Simponi may have to wait for a few months more, thanks to an FDA inspection
CSL Seqirus, the vaccine unit of Australian biotech CSL, signed a pact to provide Saudi Arabia with cell-based influenza shots and to help establish its production in-country. The move comes as part
Eli Lilly has revealed a plan to spend $1.2 billion to upgrade its plant in Carolina, Puerto Rico. The investment will add 100 manufacturing jobs and bolster the company’s capacity to produce
Healthcare facilities across America are grappling with a sustainability crisis hiding in plain sight. While hospitals focus on reducing carbon emissions and implementing green initiatives, a staggering waste stream continues to flow
The FDA has issued another complete response letter to Regeneron over its high-dose Eylea due to unresolved issues at a Novo Nordisk manufacturing plant. The company, however, is making progress in lining
The FDA slammed generics maker Hetero with a Form 483 after an inspection of one of its warehouses in India uncovered flying birds, skittering lizards and roaming cats, among a host of
CDMO Catalent has unveiled a new corporate brand, which keeps the company’s moniker the same while trading in the simple blue-against-white lettering of its previous logo with a pair of intersecting, speech